CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant.
CCR5 拮抗剂 TD-0680 采用一种新的机制来增强其对抗 HIV-1 入侵、细胞介导感染和耐药变异株的效力
期刊:Journal of Biological Chemistry
影响因子:3.9
doi:10.1074/jbc.M112.354084
Kang Yuanxi, Wu Zhiwei, Lau Terrence C K, Lu Xiaofan, Liu Li, Cheung Allen K L, Tan Zhiwu, Ng Jenny, Liang Jianguo, Wang Haibo, Li Saikam, Zheng Bojian, Li Ben, Chen Li, Chen Zhiwei
